2-aminopyrimidin-6-one exhibiting anticancer activity and antiproliferative activity and analogues

摘要

Problems such as ABL, bcr-abl, KDR, SRC, Lck, Lyn, FGFR, met, and other kinase including FGFR, met, and other kinases may also exhibit selective selectivity by c-fms, c-kit, and / or PDGF for the treatment of autoimmune diseases To provide a novel inhibitor that inhibits r kinase.Equation ICompound of the compound, or its pharmaceutically acceptable salt, enantiomer, stereoisomer, or tautomer.No selection